Global Molecular Breast Imaging Market Report

Global Molecular Breast Imaging Market Report

  • 03-09-2020

The breast imaging market is raised to acquire from an evaluated value of USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the estimated time. Mart growth is mainly focused on issues such as technical developments, the increasing frequency of breast cancer, the uprising number of screening plans as well as extending the number of meetings and symposiums focusing on giving attentiveness about the benefits of early screening and diagnosis. The developing markets, emergent government and earmarked funds to see the cumulative petition for breast cancer screening, and the successful settlement setups are likely to confront a kind of developing prospects for marketing companies
Based on technology, the breast imaging market is segmented into ionizing breast imaging, non-ionizing breast imaging, and other breast imaging technologies. The non-ionizing breast imaging section is anticipated to rise at the highest CAGR during the forecast period. Growth in this segment can be ascribed to the advantages provided by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details of diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives.
Segment review
The Global Molecular Breast Imaging Market Report involves two parts, type, and application. The product type tells the variety of available drugs in the marketplace. The report also says the possible profit prediction at the partial interval. It offers the price range of each drug. The other part of the report, application, enlightens the different ways of the product and end-users. In the report, the research workers have also turned over profits, according to the habit of the merchandise. This has also increased the demand for image sensor market in the healthcare industry. 

Key market segments
By type
•    Single Head Molecular Breast Imaging
•    Dual Head Molecular Breast Imaging

By application
•    Hospital
•    Diagnostic Center
•    Others
•    Competitive Landscape

By manufacturers
•    Dilon Technologies
•    CMR Naviscan
•    Digirad
•    GE
•    Mayo Clinic
By region
•    North America
o    U.S.
o    Canada
o    Mexico
•    Europe
o    Germany
o    France
o    U.K
o    Italy
o    Spain
o    Rest of Europe
•    Asia-pacific
o    Japan
o    China
o    India
o    Australia 
o    South Korea
o    Rest of Asia-Pacific
•    LAMEA
o    Brazil
o    Saudi Arabia
o    South Africa
o    Rest of LAMEA

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail